6919 Kangpei Biotech Announces Board Resolution on 114th Fiscal Year Restricted Stock Grant for Employees

Release Date: June 27, 115
Statement Date: June 26, 115
Statement Time: 17:21:04
Company Code: 6919
Company Name: Kangpei*
Subject: Announcement of the Board Resolution on the Benchmark Date for Capital Increase via Restricted Stock Rights for Employees in Fiscal Year 114
Applicable Clause: Clause 51
Event Date: June 26, 115
Details:
1. Event Date: 06/26/115
2. Company Name: Kangpei Biotech Co., Ltd.
3. Relationship with Company (Please enter '本公司' or 'Subsidiary'):本公司 (Our Company)
4. Cross-shareholding Ratio: Not applicable.
5. Reason for Occurrence:
(1) This company has been approved by the 114th Annual General Meeting of Shareholders and authorized for reporting effectiveness by the Financial Supervisory Commission, Executive Yuan, under document No. 1140349351 dated July 4, 114.
(2) On June 26, 115, the board of directors resolved to issue 23,000 shares of restricted stock rights for employees in fiscal year 114, with a par value of NT$0.5 per share. The capital increase benchmark date is June 26, 115. If operational adjustments are required, the chairman is authorized to make necessary modifications.
(3) Matters concerning restrictions, key agreements, or any unresolved issues related to the issuance of these restricted stock rights shall be governed by relevant laws and regulations and the provisions of the company's 'Restricted Stock Rights Issuance Rules for Fiscal Year 114'.
6. Countermeasures: None.
7. Other Matters to be Disclosed:
If the entity involved in the event or resolution is a publicly issued company or above, this major information simultaneously qualifies as a matter significantly affecting shareholders' rights or securities prices under Article 7, Paragraph 9, Clause 9 of the Enforcement Rules of the Securities and Exchange Act. However, no such matters apply in this case.